{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:46:27Z","timestamp":1783939587490,"version":"3.55.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020098","name":"IMI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Fundacao para a Ciencia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ymthe.2023.04.001","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T23:16:32Z","timestamp":1680736592000},"page":"1275-1292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease\/spinocerebellar ataxia type 3"],"prefix":"10.1016","volume":"31","author":[{"given":"David","family":"Rufino-Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia R.","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Leandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas M.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ros\u00e1rio","family":"Faro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Perfeito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana S.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia M.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Jorge","family":"Nobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5831-3307","authenticated-orcid":false,"given":"Lu\u00eds","family":"Pereira de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2023.04.001_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng1194-221","article-title":"CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1","volume":"8","author":"Kawaguchi","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2023.04.001_bib2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ng0793-300","article-title":"The gene for Machado\u2013Joseph disease maps to human chromosome 14q","volume":"4","author":"Takiyama","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2023.04.001_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1006\/geno.1994.1327","article-title":"Genetic linkage studies of Machado-Joseph disease with chromosome 14q STRPs in 16 Portuguese-Azorean kindreds","volume":"21","author":"Sequeiros","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.ymthe.2023.04.001_bib4","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/brain\/121.9.1687","article-title":"Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3","volume":"121","author":"Klockgether","year":"1998","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2023.04.001_bib5","first-page":"1513","article-title":"Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies","volume":"49","author":"Evers","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymthe.2023.04.001_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(04)00737-9","article-title":"Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis","volume":"3","author":"Sch\u00f6ls","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymthe.2023.04.001_bib7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/hmg\/4.5.807","article-title":"Molecular features of the CAG repeats and clinical manifestation of Machado-Joseph disease","volume":"4","author":"Maruyama","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2023.04.001_bib8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/hum.2018.157","article-title":"RNA interference therapy for machado-joseph disease: long-term safety profile of lentiviral vectors encoding short hairpin RNAs targeting mutant ataxin-3","volume":"30","author":"N\u00f3brega","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2023.04.001_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100086","article-title":"RNA interference mitigates motor and neuropathological deficits in a cerebellar mouse model of Machado-Joseph disease","volume":"9","author":"N\u00f3brega","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.04.001_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052396","article-title":"Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice","volume":"8","author":"N\u00f3brega","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.04.001_bib11","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1093\/hmg\/ddq111","article-title":"Silencing ataxin-3 mitigates degeneration in a rat model of Machado\u00a0\u2013 joseph disease : no role for","volume":"19","author":"Alves","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2023.04.001_bib12","doi-asserted-by":"crossref","first-page":"e3341","DOI":"10.1371\/journal.pone.0003341","article-title":"Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado- joseph disease","volume":"3","author":"Alves","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.04.001_bib13","first-page":"194","article-title":"MiRNA-mediated knockdown of ATXN3 alleviates","volume":"32","author":"Henriques","year":"2022","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.ymthe.2023.04.001_bib14","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/hmg\/ddn106","article-title":"Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease","volume":"17","author":"Alves","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2023.04.001_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.omtm.2019.10.008","article-title":"Development of an AAV-based MicroRNA gene therapy to treat machado-joseph disease","volume":"15","author":"Martier","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2023.04.001_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.omtn.2017.04.005","article-title":"Evaluation of antisense oligonucleotides targeting ATXN3 in SCA3 mouse models","volume":"7","author":"Moore","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2023.04.001_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fnmol.2015.00014","article-title":"Lentiviral vectors as tools to understand central nervous system biology in mammalian model organisms","volume":"8","author":"Parr-Brownlie","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2023.04.001_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","article-title":"Spinocerebellar ataxia","volume":"5","author":"Klockgether","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ymthe.2023.04.001_bib19","first-page":"124","article-title":"Biomaterials Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates","volume":"82","author":"Concei\u00e7\u00e3o","year":"2016","journal-title":"Machado-Joseph Dis. Neurol. phenotype"},{"key":"10.1016\/j.ymthe.2023.04.001_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2023.04.001_bib21","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1038\/s41467-021-27056-3","article-title":"GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain","volume":"12","author":"Dar","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2023.04.001_bib22","doi-asserted-by":"crossref","first-page":"eaat0195","DOI":"10.1126\/scitranslmed.aat0195","article-title":"Anchor peptide captures , targets , and loads exosomes of diverse origins for diagnostics and therapy","volume":"10","author":"Gao","year":"2018","journal-title":"Sci. Transl Med."},{"key":"10.1016\/j.ymthe.2023.04.001_bib23","first-page":"472","volume":"338","author":"Tomatis","year":"2021","journal-title":"Engineered extracellular vesicles as Brain Ther."},{"key":"10.1016\/j.ymthe.2023.04.001_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41580-022-00460-3","article-title":"Challenges and directions in studying cell\u2013cell communication by extracellular vesicles","volume":"23","author":"van Niel","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2023.04.001_bib25","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J.\u00a0Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2023.04.001_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2017.07.001","article-title":"Extracellular vesicles: novel promising delivery systems for therapy of brain diseases","volume":"262","author":"Rufino-Ramos","year":"2017","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.ymthe.2023.04.001_bib27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41556-018-0040-4","article-title":"Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation","volume":"20","author":"Zhang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2023.04.001_bib28","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.celrep.2019.01.009","article-title":"Transfer of functional cargo in exomeres","volume":"27","author":"Zhang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2023.04.001_bib29","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/s41556-021-00805-8","article-title":"Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets","volume":"23","author":"Zhang","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2023.04.001_bib30","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41556-021-00808-5","article-title":"Profiling and promise of supermeres","volume":"23","author":"Clancy","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2023.04.001_bib31","doi-asserted-by":"crossref","first-page":"7294","DOI":"10.3390\/ijms22147294","article-title":"Living proof of activity of extracellular vesicles in the central nervous system","volume":"22","author":"Mahjoum","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2023.04.001_bib32","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0516","article-title":"Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain","volume":"369","author":"Pegtel","year":"2014","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.ymthe.2023.04.001_bib33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41580-020-0251-y","article-title":"RNA delivery by extracellular vesicles in mammalian cells and its applications","volume":"21","author":"O\u2019Brien","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2023.04.001_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2023.04.001_bib35","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ymthe.2017.01.021","article-title":"Unravelling endogenous MicroRNA system dysfunction as a new pathophysiological mechanism in machado-joseph disease","volume":"25","author":"Carmona","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.04.001_bib36","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1038\/ncomms3980","article-title":"Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs","volume":"4","author":"Villarroya-Beltri","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2023.04.001_bib37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.celrep.2016.09.031","article-title":"The RNA-binding protein SYNCRIP is a component of the hepatocyte exosomal machinery controlling MicroRNA sorting article the RNA-binding protein SYNCRIP is a component of the hepatocyte exosomal machinery controlling MicroRNA sorting","volume":"17","author":"Battistelli","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2023.04.001_bib38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41586-021-04234-3","article-title":"MicroRNA sequence codes for small extracellular vesicle release and cellular retention","volume":"601","author":"Garcia-Martin","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.04.001_bib39","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19276","article-title":"Y-Box Protein 1 Is Required to Sort microRNAs into Exosomes in Cells and in a Cell-free Reaction","volume":"5","author":"Shurtleff","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2023.04.001_bib40","doi-asserted-by":"crossref","first-page":"E8987","DOI":"10.1073\/pnas.1712108114","article-title":"Broad role for YBX1 in defining the small noncoding RNA composition of exosomes","volume":"114","author":"Shurtleff","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.04.001_bib41","first-page":"498","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"HHS Public Access"},{"key":"10.1016\/j.ymthe.2023.04.001_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jconrel.2013.08.014","article-title":"Electroporation-induced siRNA precipitation obscures the ef fi ciency of siRNA loading into extracellular vesicles","volume":"172","author":"Kooijmans","year":"2013","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.ymthe.2023.04.001_bib43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41551-019-0502-4","article-title":"RNA by packaging it in extracellular vesicles via a pre-microRNA backbone","volume":"4","author":"Reshke","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2023.04.001_bib44","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/nprot.2012.131","article-title":"Exosome-mediated delivery of siRNA in\u00a0vitro and in\u00a0vivo","volume":"7","author":"El-Andaloussi","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2023.04.001_bib45","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41467-018-03733-8","article-title":"Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson\u2019s disease treatment","volume":"9","author":"Kojima","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2023.04.001_bib46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.nucmedbio.2022.06.004","article-title":"In\u00a0vivo tracking of [ 89 Zr ] Zr-labeled engineered extracellular vesicles by PET reveals organ-specific biodistribution based upon the route of administration","volume":"112\u2013113","author":"Patel","year":"2022","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ymthe.2023.04.001_bib47","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/sctm.19-0327","article-title":"Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer \u2019 s disease","volume":"9","author":"Losurdo","year":"2020","journal-title":"Stem Cells Transl Med."},{"key":"10.1016\/j.ymthe.2023.04.001_bib48","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1021\/acs.nanolett.8b04148","article-title":"Golden exosomes selectively target brain pathologies in neurodegenerative and neurodevelopmental disorders","volume":"19","author":"Perets","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.ymthe.2023.04.001_bib49","unstructured":"Nobre R.J., de Almeida L.P. Double stranded rna and uses thereof. WO\/2020\/144611. World Intellectual Property Association. July 16, 2020."},{"key":"10.1016\/j.ymthe.2023.04.001_bib50","doi-asserted-by":"crossref","first-page":"8166","DOI":"10.1074\/jbc.M114.621383","article-title":"Stabilization of exosome-targeting peptides via engineered glycosylation","volume":"290","author":"Hung","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2023.04.001_bib51","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1016\/j.biomaterials.2014.05.032","article-title":"Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery invivo","volume":"35","author":"Gy\u00f6rgy","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2023.04.001_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.04.001_bib53","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/11.9.1075","article-title":"YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit","volume":"11","author":"Cemal","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2023.04.001_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2019.101504","article-title":"Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line","volume":"39","author":"Moore","year":"2019","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.ymthe.2023.04.001_bib55","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/mt.2013.152","article-title":"Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice","volume":"21","author":"Rodr\u00edguez-Lebr\u00f3n","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.04.001_bib56","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1073\/pnas.082117599","article-title":"A DNA vector-based RNAi technology to suppress gene expression in mammalian cells","volume":"99","author":"Sui","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.04.001_bib57","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/acs.molpharmaceut.0c00461","article-title":"Design and validation of liposomal ApoE2 gene delivery system to evade blood\u2013brain barrier for effective treatment of Alzheimer\u2019s disease","volume":"18","author":"Arora","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2023.04.001_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146738","article-title":"Efficient neuronal targeting and transfection using RVG and transferrin-conjugated liposomes","volume":"1734","author":"dos Santos Rodrigues","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.ymthe.2023.04.001_bib59","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13287-020-01727-2","article-title":"Mesenchymal stem cell-derived exosomes improve motor function and attenuate neuropathology in a mouse model of Machado-Joseph disease","volume":"11","author":"You","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ymthe.2023.04.001_bib60","doi-asserted-by":"crossref","unstructured":"Chen Y shuan, Lin Y tung, C.P yu, C.P rong. miR-6780-5p-Enriched exosomes derived from butylidenephthalide-pre-conditioned human olfactory ensheathing cells via autophagy improve motor coordination and balance in a SCA3\/MJD mouse Model. Research Square; 2021. DOI: 10.21203\/rs.3.rs-820726\/v","DOI":"10.21203\/rs.3.rs-820726\/v1"},{"key":"10.1016\/j.ymthe.2023.04.001_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab054","article-title":"B RAIN AIN COMMUNICATIONS Secreted therapeutics : monitoring durability of microRNA-based gene therapies in the central nervous system","volume":"3","author":"Sogorb-gonzalez","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.ymthe.2023.04.001_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110651","article-title":"Uptake, functionality, and re-release of extracellular vesicle-encapsulated cargo","volume":"39","author":"O\u2019Brien","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2023.04.001_bib63","doi-asserted-by":"crossref","first-page":"475444","DOI":"10.7554\/eLife.47544","article-title":"Distinct mechanisms of microrna sorting into cancer cell-derived extracellular vesicle subtypes","volume":"8","author":"Temoche-Diaz","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2023.04.001_bib64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1021\/acs.nanolett.8b02689","article-title":"In\u00a0Vitro and in\u00a0vivo RNA inhibition by CD9-HuR functionalized exosomes encapsulated with miRNA or CRISPR\/dCas9","volume":"19","author":"Li","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.ymthe.2023.04.001_bib65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12967-021-03156-y","article-title":"microRNA-155-3p delivered by M2 macrophages-derived exosomes enhances the progression of medulloblastoma through regulation of WDR82","volume":"20","author":"Song","year":"2022","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.ymthe.2023.04.001_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108493","article-title":"Dendritic cell immunotherapy with miR-155 enriched tumor-derived exosome suppressed cancer growth and induced antitumor immune responses in murine model of colorectal cancer induced by CT26 cell line","volume":"104","author":"Asadirad","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ymthe.2023.04.001_bib67","article-title":"Velocity gradient separation reveals a new extracellular vesicle population enriched in miR-155 and mitochondrial DNA","volume":"10","author":"Vaillancourt","year":"2021","journal-title":"Pathog (Basel, Switzerland)"},{"key":"10.1016\/j.ymthe.2023.04.001_bib68","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12017-012-8196-8","article-title":"RVG-mediated Calpain2 gene silencing in the brain impairs learning and memory","volume":"15","author":"Zadran","year":"2013","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.ymthe.2023.04.001_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011085","article-title":"Liposome-siRNA-Peptide complexes cross the blood-brain barrier and significantly decrease PrPC on neuronal cells and PrPRES in infected cell cultures","volume":"5","author":"Pulford","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.04.001_bib70","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1093\/brain\/awab354","article-title":"Therapeutic reversal of Huntington\u2019s disease by in\u00a0vivo self-assembled siRNAs","volume":"144","author":"Zhang","year":"2021","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2023.04.001_bib71","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/mt.2010.27","article-title":"Targeted delivery of sirna to macrophages for anti-inflammatory treatment","volume":"18","author":"Kim","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.04.001_bib72","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/mt.2011.303","article-title":"Microvesicle-associated AAV vector as a novel gene delivery system","volume":"20","author":"Maguire","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.04.001_bib73","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymthe.2023.04.001_bib74","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejps.2014.04.019","article-title":"Intranasal administration of carbamazepine to mice: a direct delivery pathway for brain targeting","volume":"60","author":"Serralheiro","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ymthe.2023.04.001_bib75","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2019.04.047","article-title":"Nose-to-brain delivery of levetiracetam after intranasal administration to mice","volume":"564","author":"Gon\u00e7alves","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ymthe.2023.04.001_bib76","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.stemcr.2019.02.012","article-title":"Stearoyl CoA desaturase is essential for regulation of endoplasmic reticulum homeostasis and tumor growth in glioblastoma cancer stem cells","volume":"12","author":"Pinkham","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ymthe.2023.04.001_bib77","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jnci\/djy138","article-title":"Olfactory ensheathing cells: a trojan horse for glioma gene therapy","volume":"111","author":"Carvalho","year":"2019","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ymthe.2023.04.001_bib78","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.18632\/oncotarget.27043","article-title":"Olfactory ensheathing cells travel their natural nasal pathway to deliver therapeutics to brain tumors","volume":"10","author":"Carvalho","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2023.04.001_bib79","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1021\/acsnano.7b04495","article-title":"In\u00a0Vivo neuroimaging of exosomes using gold nanoparticles","volume":"11","author":"Betzer","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2023.04.001_bib80","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/mt.2011.164","article-title":"Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain","volume":"19","author":"Zhuang","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.04.001_bib81","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/187152709788680652","article-title":"Blood-brain barrier transport of drugs for the treatment of brain diseases","volume":"8","author":"Gabathuler","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.ymthe.2023.04.001_bib82","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2174\/1381612826666200115101544","article-title":"Nose-to-brain delivery of natural compounds for the treatment of central nervous system disorders","volume":"26","author":"Bicker","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ymthe.2023.04.001_bib83","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.crad.2012.05.019","article-title":"The trigeminal nerve: an illustrated review of its imaging anatomy and pathology","volume":"68","author":"Bathla","year":"2013","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ymthe.2023.04.001_bib84","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0006-8993(98)00862-2","article-title":"Neuronal nicotinic acetylcholine receptors in rat trigeminal ganglia","volume":"809","author":"Liu","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.ymthe.2023.04.001_bib85","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/chemse\/25.1.61","article-title":"Evidence for nicotinic acetylcholine receptors on nasal trigeminal nerve endings of the rat","volume":"25","author":"Alimohammadi","year":"2000","journal-title":"Chem. Senses"},{"key":"10.1016\/j.ymthe.2023.04.001_bib86","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/pharmaceutics12020093","article-title":"Targeting small molecule delivery to the brain and spinal cord via intranasal administration of rabies virus glycoprotein (RVG29)-modified PLGA nanoparticles","volume":"12","author":"Chung","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymthe.2023.04.001_bib87","article-title":"Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrina","volume":"1","author":"Driedonks","year":"2022","journal-title":"J Extracell Biol"},{"key":"10.1016\/j.ymthe.2023.04.001_bib88","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1038\/s41598-021-82339-5","article-title":"Intranasal delivery alleviates Machado\u2013Joseph disease","volume":"11","author":"Duarte-Neves","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2023.04.001_bib89","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/nbdi.2001.0388","article-title":"Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington\u2019s disease","volume":"8","author":"de Almeida","year":"2001","journal-title":"Neurobiol. Dis."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623001995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623001995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:09:21Z","timestamp":1761502161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001623001995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1525001623001995"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.04.001","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease\/spinocerebellar ataxia type 3","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}